Rocket Pharmaceuticals (NASDAQ:RCKT) Downgraded to Hold Rating by Leerink Partnrs
Leerink Partnrs cut shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) from a strong-buy rating to a hold rating in a research report report published on Tuesday morning,Zacks.com reports. Other analysts have also issued reports about the company. JPMorgan Chase & Co. restated a “neutral” rating on shares of Rocket Pharmaceuticals in a research note […]
Leerink Partnrs cut shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) from a strong-buy rating to a hold rating in a research report report published on Tuesday morning,Zacks.com reports. Other analysts have also issued reports about the company. JPMorgan Chase & Co. restated a “neutral” rating on shares of Rocket Pharmaceuticals in a research note […]
